Singapore markets close in 6 hours 42 minutes

Straits Times Index
3,324.06
-2.22(-0.07%)
Nikkei
39,665.33
+492.18(+1.26%)
Hang Seng
18,079.65
+6.75(+0.04%)
FTSE 100
8,247.79
-33.76(-0.41%)
Bitcoin USD
62,380.68
+1,991.12(+3.30%)
CMC Crypto 200
1,287.66
+38.54(+3.08%)

RGNX Jul 2024 17.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.3500

+0.0400

(+12.90%)

As of 01:45PM EDT. Market open.

Loading interactive chart…

Zacks
Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock?
Regenxbio (RGNX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PR Newswire
REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients
REGENXBIO Inc. (Nasdaq: RGNX) today announced it initiated enrollment in a new cohort of patients ages 1-3 in its Phase I/II AFFINITY DUCHENNE® trial to evaluate the safety and efficacy of RGX-202 in boys with Duchenne muscular dystrophy (Duchenne).
Zacks
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
Following the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation status.